VITASPRING BIOMEDICAL CO., LTD. (VSBC) Operating cash flow 2017–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2,688FY2026 · since FY2017: -$4,045 → -$2,688
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2,688 | +81.7% |
| FY2025 | -$14,675 | +58.0% |
| FY2024 | -$34,920 | +55.0% |
| FY2023 | -$77,556 | +71.2% |
| FY2022 | -$269,631 | -540.0% |
| FY2021 | -$42,130 | -40023.8% |
| FY2020 | -$105 | +99.7% |
| FY2019 | -$34,248 | -8640.6% |
| FY2018 | $401 | +109.9% |
| FY2017 | -$4,045 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating marginVSBC Free cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →